NTRA - Natera - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6323071042
Prenatal, Genetic, Cancer, NIPT, Transplantation
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company also provides Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney, heart, and lung transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas. Web URL: https://www.natera.com
Drawdown (Underwater) Chart
![Drawdown / Underwater Chart for NTRA - Natera - Stock Price & Dividends](https://www.valueray.com/images/drawdown_chart/NTRA.NASDAQ_drawdown.png)
Overall Trend and Yearly Seasonality
![Drawdown / Underwater Chart for NTRA - Natera - Stock Price & Dividends](https://www.valueray.com/images/chart/NTRA.NASDAQ_seasonality.png)
NTRA Stock Overview
Market Cap in USD | 13,758m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC SubIndustry | Biotechnology |
TER | 0.00% |
IPO / Inception | 2015-07-02 |
NTRA Stock Ratings
Growth 5y | 54.7 |
Fundamental | -44.3 |
Dividend | 0.00 |
Rel. Performance vs Sector | 3.17 |
Analysts | 4.56/5 |
Fair Price Momentum | 113.24 USD |
Fair Price DCF | - |
NTRA Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
NTRA Growth Ratios
Growth 12m | 125.40% |
Growth Correlation 12m | 78% |
Growth Correlation 3m | 43% |
CAGR 5y | 30.17% |
CAGR/Mean DD 5y | 0.92 |
Sharpe Ratio 12m | 2.52 |
Alpha vs SP500 12m | 97.92 |
Beta vs SP500 5y weekly | 1.45 |
ValueRay RSI | 11.08 |
Volatility GJR Garch 1y | 41.46% |
Price / SMA 50 | -6.27% |
Price / SMA 200 | 28.67% |
Current Volume | 2998.5k |
Average Volume 20d | 1316.1k |
External Links for NTRA Stock
News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
What is the price of NTRA stocks?
As of July 27, 2024, the stock is trading at USD 102.15 with a total of 2,998,529 shares traded.
Over the past week, the price has changed by -3.12%, over one month by -7.83%, over three months by +12.01% and over the past year by +127.05%.
As of July 27, 2024, the stock is trading at USD 102.15 with a total of 2,998,529 shares traded.
Over the past week, the price has changed by -3.12%, over one month by -7.83%, over three months by +12.01% and over the past year by +127.05%.
What are the forecast for NTRA stock price target?
According to ValueRays Forecast Model, NTRA Natera will be worth about 127.1 in July 2025. The stock is currently trading at 102.15. This means that the stock has a potential upside of +24.43%.
According to ValueRays Forecast Model, NTRA Natera will be worth about 127.1 in July 2025. The stock is currently trading at 102.15. This means that the stock has a potential upside of +24.43%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 123.4 | 20.8 |
Analysts Target Price | 71.2 | -30.3 |
ValueRay Target Price | 127.1 | 24.4 |